TISSUE PROTEOME ANALYSIS OF HORMONE RECEPTOR-POSITIVE BREAST CANCER.

被引：0
|
作者：
Yoneten, K. Karaosmanoglu [1 ]
Gunes, A. [2 ]
Kasap, M. [3 ]
Utkan, N. Z. [4 ]
Akpinar, G. [3 ]
Gurel, B. [5 ]
Guler, S. A. [4 ]
机构：
[1] Kocaeli Univ, Fac Technol, Dept Biomed Engn, Kocaeli, Turkey
[2] Derince Training & Res Hosp, Dept Gen Surg, Kocaeli, Turkey
[3] Kocaeli Univ, Fac Med, Dept Med Biol, Kocaeli, Turkey
[4] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkey
[5] Kocaeli Univ, Fac Med, Dept Med Pathol, Kocaeli, Turkey
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2204
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Proteomic prediction in hormone receptor-positive breast cancer.
    Hennessy, B. T.
    Gonzalez-Angulo, A. M.
    Lu, Y.
    Tibes, R.
    Siwak, D.
    Sahin, A.
    Kau, S.
    Hortobagyi, G. N.
    Valero, V.
    Mills, G. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 13S - 13S
  • [2] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.
    Leitzel, Kim
    Ali, Suhail M.
    Vasekar, Monali K.
    Nagabhairu, Vinod
    Marks, Eric
    Ali, Ayesha
    Krecko, Laura
    Willumsen, Nicholas
    Leeming, Diana Julie
    Karsdal, Morten Asser
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer.
    Senkus-Konefka, Elzbieta
    Popeda, Marta
    Kunc, Michal
    Bienkowski, Michal
    Braun, Marcin
    Lacko, Aleksandra
    Radecka, Barbara
    Pikiel, Joanna
    Litwiniuk, Maria
    Pogoda, Katarzyna
    Izycka-Swieszewska, Ewa
    Zaczek, Anna Joanna
    Biernat, Wojciech
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Disparities in Hormone Receptor-Positive Breast Cancer
    Ogayo, Esther R.
    Mittendorf, Elizabeth A.
    Kantor, Olga
    CURRENT BREAST CANCER REPORTS, 2024, 16 (01) : 106 - 115
  • [6] Androgen Receptor in Hormone Receptor-Positive Breast Cancer
    Khan, Ashfia Fatima
    Karami, Samaneh
    Peidl, Anthony S.
    Waiters, Kacie D.
    Babajide, Mariam Funmi
    Bawa-Khalfe, Tasneem
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [7] Palbociclib for hormone receptor-positive breast cancer
    Harding, Emilia
    LANCET ONCOLOGY, 2015, 16 (07): : E318 - E318
  • [8] Disparities in Hormone Receptor-Positive Breast Cancer
    Esther R. Ogayo
    Elizabeth A. Mittendorf
    Olga Kantor
    Current Breast Cancer Reports, 2024, 16 : 106 - 115
  • [9] Progesterone receptor signaling in estrogen receptor-positive breast cancer.
    Young, Amy
    Guan, Jane
    Daemen, Anneleen
    Friedman, Lori
    Lin, Kui
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 81 - 81
  • [10] Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer.
    Mayte Villarreal-Garza, Cynthia
    Arce-Salinas, Claudia
    Lasa, Federico
    Reynoso, Nancy
    Antonio Matus, Juan
    Lara-Medina, Fernando
    Bargallo-Rocha, Enrique
    Flores Diaz, Diana Fabiola
    Shaw, Robin J.
    Alvarado-Miranda, Alberto
    Jaime Castaneda, Noel
    Alejandra Martinez-Cannon, Bertha
    Mohar, Alejandro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345